Login / Signup

Ablative therapy with UGN-102 for low-grade intermediate risk non-muscle-invasive bladder cancer: ready for primetime?

Benjamin LichtbrounSaum GhodoussipourVignesh T Packiam
Published in: Translational andrology and urology (2024)
Keyphrases
  • low grade
  • muscle invasive bladder cancer
  • high grade
  • stem cells